Table 4.
Stem cell source | EC Culture type | Study objective | BBB Integrity | Ref | |
---|---|---|---|---|---|
TEER (Ω.cm2) * | Pe (x 10−3 cm/sec) | ||||
IMR90-c4 hiPSC cell line | Monoculture or co-culture (priming) with human brain pericytes and NPC-derived neuron/astrocyte mixtures; Static; Retinoic acid as inductive factor |
Development of a fully humanized in vitro BBB (neurovascular unit) model and enrichment by retinoic acid | 5160 | Sucrose, <0.006 | [110, 120] |
Monoculture or co-culture with rat astrocytes; Static; | Development of a robust human BBB model and role of Wnt/β-catenin signaling in BBB development | 1450 | Sucrose, 0.034 Inulin, 0.03 |
[121] | |
Monoculture; Static; Retinoic acid as inductive factor |
Anticancer drug permeability | >1500 | Sucrose, 0.13 | [124] | |
Variable effects of ECM and culture medium on stem cell differentiation efficiency | ~1400 | NaF, 0.04 | [123] | ||
Co-cultured with rat astrocytes; flow-based; Retinoic acid as inductive factor |
Development of BBB-on-a Chip microfluidic model with minimal shear stress for in vitro drug permeability screen | >4300 | Dextran (4–70kDa), 0.0001–0.001 | [122] | |
H9 hESC cell line DF19-9-11T hiPSC cell line; DF6-9-9T hiPSC cell line |
Monoculture or co-culture with rat astrocytes; Static | BMEC differentiation efficiency of various pluripotent stem cells to model human BBB | >700 | n.a | [121] |
Monoculture or co-culture with human brain pericytes and neuron/astrocyte; Static; Retinoic acid as inductive factor |
Development of a fully humanized in vitro BBB (neurovascular unit) model and enrichment by retinoic acid | 4740a 1680b |
n.a. | [120] | |
Embryonic rat/human neural progenitor cells (NPC) | NPC derived neurons + astrocytes mixture co-culture with rat BMECs; Static | Optimization of NPC differentiation to induce in vivo like BBB phenotype in rat BMECs | ~250 | n.a. | [10] |
Co-culture with rat astrocytes or embryonic NPCs; Static | To understand the embryonic BBB development and BBB-inductive capacity of NPCs including BMEC and NPC cross-talk | 110 | NaF, 0.33 | ||
CD34+ human umbilical cord blood (hematopoietic) cells | Co-culture with human brain pericytes; Static; VEGF as stimulant |
Breast cancer cells and BMEC interactions in brain metastases | n.a. | LY, 0.53–0.75 | [113] [114] |
Development and predictive validity of a functional in vitro human BBB model and the role of Wnt signaling in BBB induction | 180 | LY, 0.61 | [112] | ||
Human cord blood endothelial progenitor cells | Co-cultured with rat astrocytes; Static | Differentiation of circulating endothelial progenitor cells to BBB phenotype and comparison with hCMEC/D3 | n.a. | LY, 1.25 | [111] |
After optimization of several culture conditions including co-cultures, serum%, seeding density, differentiation days and medium, supplementation of enhancer
DF-19-9-11T hiPSC cell line;
H9 hECS cell line;